tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Zemansky, 13 are a BUY (54.17%), 10 are a HOLD (41.67%), 1 are a SELL (4.17%).
Analyst Jason Zemansky, currently employed at BAML, carries an average stock price target met ratio of 46.53% that have a potential upside of 19.48% achieved within 86 days.
Jason Zemansky’s has documented 47 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 09-Oct-2024.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/24/2024. The price target of $40 was fulfilled within 4 days with a profit of $18 (81.82%) receiving and performance score of 204.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.73 (136.22%)
$3
1 months 13 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
4 months 19 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.27 (-21.26%)
$1.5
9 months 22 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
10 months 21 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.73 (608.66%)
1 years 5 months 28 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Jason Zemansky is most bullish on?
Which stock is Jason Zemansky is most reserved on?
What Year was the first public recommendation made by Jason Zemansky?
